ASSET PURCHASE AGREEMENT Dated February 27, 2024 by and among KINNATE BIOPHARMA INC. AND PIERRE FABRE MÉDICAMENT, SASAsset Purchase Agreement • March 1st, 2024 • Kinnate Biopharma Inc. • Pharmaceutical preparations • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”), effective as of February 27, 2024 (the “Effective Date”), is made and entered into by and among Kinnate BioPharma Inc., a Delaware corporation (“Seller”) and Pierre Fabre Médicament, SAS, a corporation incorporated under the laws of France having its offices and principal place of business at Les Cauquillous, 81500 Lavaur, France (“Buyer”). Seller and Buyer may each be referred to as herein individually as a “Party” and collectively as the “Parties”.
